This article examines the influences on executives' continuing education in hospitals. It uses data from a national survey on professional development conducted in 2009 by the American College of Healthcare Executives (ACHE) to explore how organizational and individual characteristics are related to the amount of continuing education (CE) taken by chief executive officers (CEOs) and the commitment to CE by their senior managers. Our findings suggest that the organizational characteristics of ownership, size, and region and the individual characteristics of gender, professional affiliation, and the focus of CE may influence how much CE CEOs take. CEOs from for-profit, larger hospitals and ACHE members tend to take less CE. Likewise, senior managers' commitment to CE is influenced by region, gender, the CEO's personal CE hours, and the focus of the CE. Surprisingly, ACHE membership is associated with lower amounts of personal CEO CE. Also, female CEOs appear to engender greater commitment to CE in their senior managers. Finally, CE focused on change increases the senior managers' commitment, while a focus on new technology lessens it. For those organizations seeking to meet current and future challenges by creating a learning organization, CE is essential. Understanding factors that influence the amount of and commitment to CE is important. We hope our research adds to this understanding and that leaders will seek to improve the dedication and value of CE in their organizations.
Download full-text PDF |
Source |
---|
J Community Genet
January 2025
Department of Human Genetics, Emory University School of Medicine, 101 Woodruff Circle, 7th Floor Suite 7130, Atlanta, GA, 30322, USA.
As the role of primary care providers (PCPs) in genetic medicine increases, there is a need for training related to the integration of genetics into primary care. However, little is known about PCPs' attitudes towards and perceived needs for such training. We conducted semi-structured interviews with nine PCPs to capture information about their perceptions of their role in genetics and their continuing medical educational needs related to genetics in primary care, and we conducted thematic analysis.
View Article and Find Full Text PDFBMJ Open Gastroenterol
January 2025
Inflammatory Bowel Disease Center and Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Objective: Etrasimod is an oral, once-daily, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment of moderately to severely active ulcerative colitis (UC). S1P receptor expression on cardiac cells is involved in cardiac conduction. We report cardiovascular treatment-emergent adverse events (TEAEs) associated with S1P receptor modulators and other cardiovascular events in the etrasimod UC clinical programme.
View Article and Find Full Text PDFJ Scleroderma Relat Disord
January 2025
Division of Pulmonary and Critical Care, Weill Cornell Medicine, New York, NY, USA.
Background: Systemic sclerosis is a chronic and rare connective tissue disease with multiorgan effects, including interstitial lung disease (ILD). Navigating systemic sclerosis-interstitial lung disease presents a challenge for patients due to the gaps in patient education, which can impact patient health and quality of life. This study utilized the nominal group technique to identify priority knowledge gaps among patients with systemic sclerosis-interstitial lung disease and inform future educational interventions and research.
View Article and Find Full Text PDFJ CME
January 2025
DKBmed, New York, NY, USA.
Diabetic retinopathy (DR) is a public health issue affecting millions in the United States and Europe. However, despite strong recommendations for screening at regular intervals by many professional societies, including the American Diabetes Association and the American Academy of Ophthalmology, screening rates remain suboptimal, with only 50-70% of patients with diabetes adhering to recommended annual eye exams. Barriers to screening include lack of awareness, socioeconomic factors, health care system fragmentation, and workforce shortages, among others.
View Article and Find Full Text PDFEur J Pediatr
January 2025
Pediatric Nursing, Faculty of Nursing Affiliated to Benha University, Benha, Egypt.
Both term and preterm infants are susceptible to pathological jaundice, a frequent condition that can cause long-lasting neurological damage. A novel treatment for indirect pathological hyperbilirubinemia is bilisphere phototherapy, which lowers total serum bilirubin just as well as exchange transfusions. A quasi-experimental research design was utilized in the current study.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!